Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two New Kits Designed to Promote the Study of RNA-Protein Interactions

By LabMedica International staff writers
Posted on 28 Jun 2010
Two related self-contained kits allow molecular biologists to probe RNA-protein complexes using a modernized version the RNA electrophoretic mobility shift assay (EMSA) technique that replaces radioactive labeling with chemiluminescent detection.

The kits are manufactured by two subdivisions of Thermo Fisher Scientific Inc. More...
(Milford, MA, USA). The first is the LightShift RNA EMSA Kit, which the manufacturer says is the first commercially available EMSA kit. The protocol is based on a biotinylated RNA fragment used to probe protein samples. RNA-protein complexes are then monitored by changes in electrophoretic migration patterns. To detect these changes, a chemiluminescent detection method is used that provides sensitivity comparable to detection of a radioactive label.

Preparing the biotinylated probe in-house is made easy with the second kit, the Thermo Scientific Pierce RNA 3' End Biotinylation Kit. This kit provides the reagents required to produce biotinylated RNA probes for use in chemiluminescent or other detection methods. An enzymatic procedure is used to attach a single biotinylated nucleotide to the 3′ end of an RNA strand that is 22 to 450 nucleotides in length. The reaction can be completed in 30 minutes to two hours.

The biotinylated RNA probes produced in-house cost much less than commercial biotinylated RNA probes. The complete kit contains an unlabeled RNA strand to use as a positive control, a biotinylated-RNA probe standard, RNase inhibitor, glycogen, and ligation-enhancing reagents.

Related Links:
Thermo Fisher Scientific Inc.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.